Dr. Homan Abdollahzadeh, MD

Dr. Abdollahzadeh practices at Advanced Endoscopy Centers in La Quinta, California.

Dr. Abdollahzadeh's NPI, 1184634826, was assigned on August 8, 2006. Dr. Abdollahzadeh graduated from Wayne State University School Of Medicine in 1995. Dr. Abdollahzadeh holds California license A60802.

Dr. Abdollahzadeh's primary practice is Advanced Endoscopy Centers, at 47120 Dune Palms Road Suite 111, La Quinta, CA 92253. The practice phone is (760) 219-0155.

Dr. Abdollahzadeh's primary practice is Advanced Endoscopy Centers in La Quinta, California. Dr. Abdollahzadeh is also affiliated with Eisenhower Health. The medical group on file is Eisenhower Medical Associates. Dmand AI also links Dr. Abdollahzadeh to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdollahzadeh practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Abdollahzadeh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Abdollahzadeh is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Abdollahzadeh is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Abdollahzadeh treats.

CMS data shows 688 Medicare services from Dr. Abdollahzadeh across 9 procedure codes in 2024, for 438 Medicare patients. Medicare paid $64,350 for them.

CMS counts 438 Medicare patients who saw Dr. Abdollahzadeh in 2024. The largest group is 65 to 74, with 231 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdollahzadeh's median patient age at 66, with 52% women.

In 2024, Dr. Abdollahzadeh wrote 4,969 Medicare Part D claims for 3,378 patients. 59% of them were for generic drugs. CMS names the drug for 4,729 of them, across 38 drugs with 11 or more claims each, at $1,021,749 in total drug cost. In 2023, CMS named 3,992 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Abdollahzadeh for performance year 2024, reported as part of a group. Dr. Abdollahzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdollahzadeh as offering telehealth. CMS counts 214 procedures of colonoscopy by Dr. Abdollahzadeh, more than 94% of the clinicians it reports for that procedure.

Dmand AI links Dr. Abdollahzadeh to 1 clinical trial. Conditions studied include Thrombocytopenia and Cytopenia. Open Payments lists research payments to Dr. Abdollahzadeh that name 1 trial.

CMS Open Payments shows 198 general payments to Dr. Abdollahzadeh from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. RedHill Biopharma Inc. paid the most, $1,665. It also lists 4 research payments totaling $2,656 in 2019, naming 1 clinical trial.

Dr. Abdollahzadeh graduated from Wayne State University School Of Medicine in 1995.

Dr. Abdollahzadeh is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.